Social networks
878Activities
Technologies
Entity types
Location
CIELL - HEXAGONE - AMU, C.R.O.U.S., 163 Av. de Luminy, 13009 Marseille, France
Marseille
France
Employees
Scale: 2-10
Estimated: 2
Engaged corporates
0Added in Motherbase
5 years, 1 month agoCORAL BIOME PHARMA
Live cultured corals for Drug discovery
Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases.
Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity.
We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research and development’s needs. We already patented a promising anti-cancer drug, actually under pre-clinical trial and identified numerous new candidates.
Bioprospection, Aquaculture, Drug discovery, Anti-cancer drugs, and Marine Natural Compounds
CORAL BIOME PHARMA
Live cultured corals for Drug discovery
Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases.
Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity.
We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research and development’s needs. We already patented a promising anti-cancer drug, actually under pre-clinical trial and identified numerous new candidates.